| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $24,041,247 ) (Continued on the next page) |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 001 | 3 | NIH | 12/26/2025 | $120,128 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 7 | NIH | 1/23/2026 | $51,280 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 21 | NIH | 12/9/2025 | $1,385,340 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24HG013233 | AnVIL Clinical Environment for Innovation and Translation (ACE-IT) | 000 | 3 | NIH | 1/29/2026 | $1,429,420 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24TR004432 | Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | 003 | 3 | NIH | 1/16/2026 | $326,759 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI167789 | Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients | 000 | 5 | NIH | 1/27/2026 | $812,893 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R34MH132711 | Developing and testing a text-messaging intervention to support parents after their child's psychiatric emergency | 000 | 3 | NIH | 1/26/2026 | $260,650 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 001 | 3 | NIH | 1/12/2026 | $93,723 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $17,925 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $56,277 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R21AG093374 | Molecular signatures and markers of erythropoietin competence in the kidney | 000 | 1 | NIH | 1/28/2026 | $481,250 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS141191 | Cerebrospinal fluid dynamics in Huntington's disease | 000 | 2 | NIH | 1/14/2026 | $558,967 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH132022 | Next generation transcranial ultrasound-based neuromodulation using phase shift nanoemulsions | 000 | 4 | NIH | 2/10/2026 | $765,144 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL161095 | Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | 000 | 5 | NIH | 2/12/2026 | $558,202 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 3 | NIH | 12/29/2025 | $616,459 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131529 | Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral Therapy | 000 | 5 | NIH | 1/16/2026 | $856,050 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131104 | Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular disease | 000 | 5 | NIH | 12/23/2025 | $490,258 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131070 | The Origins of Human Anti-Insulin B Lymphocytes in Type 1 Diabetes | 000 | 5 | NIH | 1/15/2026 | $421,441 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK132669 | Arginine regulation of alpha cell proliferation and function | 000 | 5 | NIH | 1/16/2026 | $412,210 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01EY024997 | Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma | 000 | 10 | NIH | 1/27/2026 | $447,851 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01EY024997 | Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma | 001 | 10 | NIH | 1/30/2026 | $0 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01EY036002 | Investigating the role of cGMP signaling in glaucomatous neurodegeneration | 000 | 2 | NIH | 1/29/2026 | $524,682 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK135950 | in vivo MR characterization of pathological changes in liver microstructures | 000 | 3 | NIH | 1/16/2026 | $387,557 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK141801 | Liver and kidney responses to bilirubin as a nuclear receptor hormone | 000 | 2 | NIH | 12/10/2025 | $380,625 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA279249 | Secondary Molecular Imaging (SMI) for head and neck cancer | 000 | 3 | NIH | 1/30/2026 | $343,509 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA289528 | Molecular Mediators of Cell-free DNA biogenesis | 000 | 2 | NIH | 12/11/2025 | $603,132 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG076785 | Common Inflammation Pathways between Aging and Hypertension That Weaken Bone | 000 | 5 | NIH | 1/23/2026 | $458,836 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG085873 | REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | 000 | 3 | NIH | 2/6/2026 | $6,100,339 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 1/13/2026 | $766,423 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR080629 | Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies | 001 | 5 | NIH | 2/9/2026 | $372,447 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI180038 | Human M Cells Require Coronin 1a | 000 | 3 | NIH | 12/31/2025 | $706,382 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 001 | 1 | NIH | 1/9/2026 | $0 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 000 | 1 | NIH | 12/30/2025 | $734,957 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DA059690 | Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia | 000 | 3 | NIH | 2/10/2026 | $185,544 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 001 | 1 | NIH | 12/19/2025 | $2,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K25AG076864 | Development and Application of T1rho Dispersion Imaging of Aging Muscle | 000 | 4 | NIH | 1/15/2026 | $75,600 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08EY032620 | Mechanisms of Photoreceptor Contribution to Retinal Inflammation in Diabetic Retinopathy | 000 | 5 | NIH | 1/9/2026 | $207,847 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08AI185260 | A Translational Bioinformatics Approach for Phenotyping and Genetic Risk of Severe Cutaneous Adverse Drug Reactions | 000 | 2 | NIH | 12/31/2025 | $186,332 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08DA058046 | Measuring and modifying delay discounting as a mechanism of smoking in pregnancy | 000 | 3 | NIH | 2/10/2026 | $185,304 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 001 | 5 | NIH | 2/9/2026 | $87,561 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 5 | NIH | 2/2/2026 | $160,132 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 5 | NIH | 2/2/2026 | $50,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 00 | 4 | CDC | 1/5/2026 | $450,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 000 | 3 | NIH | 12/18/2025 | $181,255 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG090523 | The Effect of Serum Psychotropic Drug Levels and Drug Metabolizer Status on Delirium Duration and Long-term Cognition | 000 | 1 | NIH | 11/19/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG069795 | Parathyroid hormone (PTH) modulates lipid metabolism in the skeletal niche | 001 | 5 | NIH | 2/11/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23HL151871 | The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30AG086403 | Vanderbilt Alzheimer's Disease Research Center | 000 | 1 | NIH | 1/23/2026 | $0 |
| | 2026 | 2025 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K99LM014429 | Development and implementation of statistical machine learning methods to shorten rare disease odysseys | 000 | 2 | NIH | 1/19/2026 | $0 |
|
